NL166931C - Werkwijze ter bereiding of vervaardiging van een farma- ceutisch preparaat met beta-adrenergische blokkeer- werking, en werkwijze ter bereiding van 5- of 8- -(2-hydroxy-3-alkylamino)propoxycarbostyrillen. - Google Patents

Werkwijze ter bereiding of vervaardiging van een farma- ceutisch preparaat met beta-adrenergische blokkeer- werking, en werkwijze ter bereiding van 5- of 8- -(2-hydroxy-3-alkylamino)propoxycarbostyrillen.

Info

Publication number
NL166931C
NL166931C NL7317090.A NL7317090A NL166931C NL 166931 C NL166931 C NL 166931C NL 7317090 A NL7317090 A NL 7317090A NL 166931 C NL166931 C NL 166931C
Authority
NL
Netherlands
Prior art keywords
preparing
propoxycarbostyrills
pharmacic
alkylamino
beta
Prior art date
Application number
NL7317090.A
Other languages
English (en)
Dutch (nl)
Other versions
NL166931B (nl
NL7317090A (fr
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NL7317090A publication Critical patent/NL7317090A/xx
Publication of NL166931B publication Critical patent/NL166931B/xx
Application granted granted Critical
Publication of NL166931C publication Critical patent/NL166931C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL7317090.A 1972-12-14 1973-12-13 Werkwijze ter bereiding of vervaardiging van een farma- ceutisch preparaat met beta-adrenergische blokkeer- werking, en werkwijze ter bereiding van 5- of 8- -(2-hydroxy-3-alkylamino)propoxycarbostyrillen. NL166931C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47125857A JPS5239035B2 (fr) 1972-12-14 1972-12-14

Publications (3)

Publication Number Publication Date
NL7317090A NL7317090A (fr) 1974-06-18
NL166931B NL166931B (nl) 1981-05-15
NL166931C true NL166931C (nl) 1981-10-15

Family

ID=14920647

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7317090.A NL166931C (nl) 1972-12-14 1973-12-13 Werkwijze ter bereiding of vervaardiging van een farma- ceutisch preparaat met beta-adrenergische blokkeer- werking, en werkwijze ter bereiding van 5- of 8- -(2-hydroxy-3-alkylamino)propoxycarbostyrillen.

Country Status (11)

Country Link
US (1) US3953456A (fr)
JP (1) JPS5239035B2 (fr)
AR (1) AR197270A1 (fr)
BE (1) BE808593A (fr)
CA (1) CA1022555A (fr)
CH (1) CH589060A5 (fr)
DE (1) DE2362278C2 (fr)
DK (1) DK136861B (fr)
ES (1) ES421430A1 (fr)
FR (1) FR2210408B1 (fr)
NL (1) NL166931C (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
GB1504424A (en) * 1975-08-09 1978-03-22 Beecham Group Ltd Isoquinoline-derived aminoethers
CH619453A5 (fr) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
DE2719562C2 (de) * 1976-05-08 1986-05-07 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo 3, 4-Dihydrocarbostyrilderivate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
US4139537A (en) * 1976-06-29 1979-02-13 Cooper Laboratories, Inc. 3-Aryloxy-1-(2- or 4-iminodihydro-1-pyridyl)-2-propanol antiarrhythmic compounds
NZ187452A (en) * 1977-06-10 1980-05-27 Otsuka Pharma Co Ltd N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DE2934609A1 (de) 1979-08-28 1981-03-12 Cassella Ag, 6000 Frankfurt Tetrahydrochinolinderivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen.
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
ES2048108B1 (es) * 1992-07-17 1994-10-01 Lusochimica Spa Procedimiento para la preparacion de 5-(3-terc-butilamino-2-hidroxipropoxi)-3,4-dihidrocarboestirilo.
CN101622243B (zh) 2007-02-28 2013-12-04 旭化成制药株式会社 磺酰胺衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
GB1047927A (en) * 1964-03-09 1966-11-09 Ici Ltd Alkanolamine derivatives
GB1079989A (en) * 1965-09-28 1967-08-16 Ici Ltd Carbocyclic propanolamines

Also Published As

Publication number Publication date
AU6338573A (en) 1975-07-10
FR2210408A1 (fr) 1974-07-12
DE2362278A1 (de) 1974-06-20
JPS4981372A (fr) 1974-08-06
DE2362278C2 (de) 1983-03-24
DK136861C (fr) 1978-05-08
ES421430A1 (es) 1976-05-01
NL166931B (nl) 1981-05-15
NL7317090A (fr) 1974-06-18
DK136861B (da) 1977-12-05
CA1022555A (fr) 1977-12-13
JPS5239035B2 (fr) 1977-10-03
CH589060A5 (fr) 1977-06-30
AR197270A1 (es) 1974-03-22
FR2210408B1 (fr) 1977-03-11
US3953456A (en) 1976-04-27
BE808593A (fr) 1974-03-29

Similar Documents

Publication Publication Date Title
NL170143C (nl) Werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat met anti-ontstekingsactiviteit, alsmede werkwijze ter bereiding van daarvoor geschikte polyarylimidazolen.
NL170428B (nl) Werkwijze ter vervaardiging van een voorwerp van pullulan.
NL172495C (nl) Werkwijze ter bereiding van zeer zuiver radioactief molybdeen-99.
NL159083B (nl) Werkwijze ter bereiding van chinonen.
NL166931C (nl) Werkwijze ter bereiding of vervaardiging van een farma- ceutisch preparaat met beta-adrenergische blokkeer- werking, en werkwijze ter bereiding van 5- of 8- -(2-hydroxy-3-alkylamino)propoxycarbostyrillen.
NL175528C (nl) Werkwijze ter bereiding van een thermohardend bekledingspreparaat, alsmede daarmede verkregen voorwerpen.
NL178258B (nl) Werkwijze ter bereiding van een insulinezout-protaminecomplex en werkwijze ter bereiding van een insulinepreparaat.
NL174547B (nl) Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL173628C (nl) Werkwijze ter bereiding van alfa-aluminiumoxyde.
NL147162B (nl) Werkwijze ter bereiding van polybutenameren.
NL149834B (nl) Werkwijze ter bereiding van een thermoplastisch preparaat, alsmede daaruit vervaardigd gevormd voortbrengsel.
NL156710B (nl) Werkwijze ter bereiding van sorptiemiddelen, alsmede gevormde sorptiemiddelen bereid volgens deze werkwijze.
CA973893A (en) Process for preparing cyanoethylated ketones
CH530191A (it) Procedimento per la fabbricazione di scaffalature in genere, e scaffalature ottenute mediante tale procedimento
NL174356C (nl) Werkwijze ter bereiding van distannanen.
NL7903399A (nl) Werkwijze ter bereiding van 2-triazolobenzodiazepinen.
CA1023138A (fr) Procede de fabrication d'elements tubulaires poreux
NL168335B (nl) Werkwijze ter bereiding van een glycerol-standaard- oplossing.
CA969839A (en) Semiconductor rod manufacturing method
NL174663C (nl) Werkwijze ter bereiding van kunstlederachtige, dunwandige gevormde voortbrengsels.
NL180069C (nl) Werkwijze ter bereiding of vervaardiging van een anthelminticum.
GB1323159A (en) Process for the production of amylo-1,6-glucosidase
RO76977A (fr) Procede pour la preparation des diphenylmethoxyethylamines
NL160565B (nl) Werkwijze ter bereiding van een preparaat met analgetische werking, gevormd preparaat, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen.
NL171349C (nl) Werkwijze ter bereiding van chloorcyaan.

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee